Real life use of dolutegravir doravirine dual regimen in experienced elderly PLWH with multiple comorbidities and on polypharmacy: A retrospective analysis

By increasing life expectancy of people living with HIV, the most clinical challenge is managing both drug-to-drug interactions and comorbidities (especially metabolic). Doravirine (DOR), a new non-nucleoside reverse transcriptase inhibitor, recently approved for the treatment of HIV, could be a goo...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazzitelli, Maria, Sasset, Lolita, Leoni, Davide, Putaggio, Cristina, Cattelan, Anna Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4850
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718210/
https://www.ncbi.nlm.nih.gov/pubmed/34967394
http://dx.doi.org/10.1097/MD.0000000000028488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718210/
https://www.ncbi.nlm.nih.gov/pubmed/34967394
http://dx.doi.org/10.1097/MD.0000000000028488

Ejemplares similares